Chemotherapy-Induced Nausea and Vomiting and Mucositis Flashcards
What percentage of oncology patients experience some type of nausea or vomiting
90%
What the three main areas of the body involved in CINV
Central nervous system, peripheral nervous system, and the GI tract
What are the two key reigons of the brainstem involved in CINV, what is the flow between the two
Chemoreceptor trigger zone and Vomitting center, CTZ stimulates the VC
What are the two pathways of the CTZ
Peripheral: chemotherapy directly irritating cells in the GI tract releasing serotonin stimulating the CTZ leading to stimulating VC (Acute CINV)
Central: Substance P binds to NK-1 receptors and dopamine is stimulated by CTZ (Delayed CINV)
Which patient risk factors increase the likelihood of CINV
Being female, age less than 50, history of motion sickness, previous CINV, N/V with past pregnancies, low alcohol use, Anxiety
T/F: Alcohol use makes it more likely a patient will have CINV
False: Alcohol use is actually PROTECTIVE against CINV
What are treatment related risk factors of CINV
Drug, dose, route, schedule, radiation, surgery
What are autonomic symptoms of nausea, what receptors are involved
Pallor, tachycardia, diaphoresis, salivation/ dopamine, serotonin, muscarinic, and histamine
T/F: Grade 1 and 2 in CINV can be resolved with outpatient care while Grade 3 and 4 may require hospitalization
True
What are the types of CINV
Acute. delayed, breakthrough, anticipatory, refractory
What causes acute CINV, when does it occur, peaks and resolves, mediated by
ANY CHEMOTHERAPY, within first 24 hours following chemotherapy, peaks after 5 hours to 6 hours and resolves in 24 hours, mediated by serotonin
What causes delayed CINV, when does it occur, peaks and resolves
Associated with platinum, anthracyclines, and nitrogen mustards/ 24 hours after chemotherapy, peaks at 48 hours to 72 hours and can last from 5 to 7 days, mediated by dopamine and NK-1 more than serotonin
What is breakthrough CINV, incidence, solution
Occurs despite prophylactic treatment and requires rescue with antiemetics, 10-40%, rescue antiemetics should utilize a different MOA
What is refractory CINV, solution
Occurs during subsequent cycles due to inadequate control in the previous cycles so patients have poor responses to multiple antiemetics
What is anticipatory CINV, triggers
Occurs before patient recieve their next chemotherapy cycle (mostly nausea)/ sight, smell, taste, sounds, thoughts, or anxiety associated with chemo
What is the corticosteroid used in CINV, what is it indicated in, MOA
Dexamethasone/ acute, delayed, breakthrough, refractory/ interaction with serotonin receptors, activation of glucocorticoid receptors, interaction with CTZ
T/F: Dexamtheasone has slow onset and low bioavailability
False: Dexamethasone has FAST onset and HIGH bioavailability
What are adverse effects of dexamethasone
Insomnia (take before 4 pm), GI upset (take with food), appetite stimulant (eat), anxiety, hypertension